S&P 500 is up 12.3% in 2025 and the Nasdaq is up 15.3% through Nov. 21. Both beat their long-term 10% average. A 10-year ...

Novo Nordisk stock dropped 9% as it said its trial of its weight-loss drug to treat Alzheimer's didn't show a delay in disease progress. Biogen, which sells an Alzheimer drug, rose 5%. Alphabet stock ...

The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly.

Dow Jones Top Markets Headlines at 7 AM ET: U.S. Stock Futures Mostly Higher | German ... U.S. stock futures were mostly higher, boosted by hopes the Fed will cut interest rates next month. Confidence ...

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

The Dow Jones Industrial Average rose 493.15 points, or 1.08%, to 46,245.41. The S&P 500 gained 0.98% to 6,602.99, and the Nasdaq Composite added 0.88% to 22,273.08.

That's the share of GDP growth, adjusted for inflation, that AI business investment may have accounted for in the first six ...

Shares of Novo Nordisk A/S took a dive in early Monday trading after the drugmaker said oral semaglutide, which is the key ingredient in the company's Ozempic and Wegovy diabetes and weight-loss drugs ...

The domestic equity benchmarks slipped for a second straight session as profit booking and caution ahead of the US Feds December policy outlook kept sentiment muted. Traders also stayed guarded amid ...

Stock futures pointed higher Monday to begin a holiday-shortened week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Asian shares are mostly higher and U.S. futures have advanced after an upbeat end to last week on Wall Street. Markets in ...